What is neoadjuvant immunotherapy for skin cancer?
Source: MD Anderson Cancer Center, October 2022
Neoadjuvant immunotherapy is an immunotherapy that’s started before surgery. It is almost always followed with additional doses of adjuvant immunotherapy after surgery.
Several recent studies led by MD Anderson clinical researchers have shown that patients may benefit from starting immunotherapy before surgery to remove high-risk skin cancers.
We spoke to Rodabe Amaria, M.D., Neil Gross, M.D., and Sapna Patel, M.D., to learn more.